Pakistan gives go-ahead to Phase 3 COVID-19 vaccine trial

Pakistan’s drug regulator greenlit the country’s first Phase 3 clinical trial for a potential COVID19 vaccine, which is being developed by China’s CanSino Biologics (CanSino) and Beijing Institute of Biotechnology.

Read the Rest at News18

Leave a Reply

Your email address will not be published. Required fields are marked *